Across TCGA pan-cancer cohorts, USP24P1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of USP24P1’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where USP24P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types USP24P1 is over-expressed in tumor.
BRCA are the cancer types where USP24P1 tumor–normal differential expression is most reproducible.